来自MSN11 个月
Medtronic's Latest Generation Of Transcatheter Aortic Valve Replacement Implant Passes FDA ...
Wednesday, the FDA approved Medtronic plc’s (NYSE:MDT) Evolut FX+ transcatheter aortic valve replacement (TAVR) system for symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system ...